The 6ixth Event
Louisville, United States5
4M
4
1.67
0.20
- Stages of investment
- Areas of investment
Investor highlights
- Industry focus
- Stage focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 5
- Lead investments
- 0
- Rounds per year
- 1.67
- Follow on index
- 0.20
- Investments by industry
- Information Technology (3)
- Business Information Systems (2)
- Management Information Systems (2)
- Training (1)
- Career Planning (1) Show 4 more
- Investments by region
- United States (5)
- Peak activity year
- 2020
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Group Appearance index
- 0.80
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Harmonic.ai | 01 Mar 2021 | Information Technology, Management Information Systems, Business Information Systems | Seed | 7M | United States, California, San Francisco |
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Kainova Therapeutics , a Montreal, Canada-based clinical-stage biopharmaceutical company | Oct 2, 2026 | Biopharmaceutical, G protein-coupled receptors (GPCRs), Immuno-oncology, Inflammation | - | 32 CAD | Canada-based clinical-stage biopharmaceutical company, a Montreal |
| Fore Biotherapeutics | May 23, 2025 | Biotherapeutics, BRAF inhibitors, Drug Development, Functional Genomics, Oncology, Precision Oncology, Small-Molecule Inhibitors | - | 38000000 USD | Philadelphia, Pennsylvania |
| Vividi India Finance | Jan 24, 2024 | Financial Services, Fintech, NBFC, Non-Banking Financial Company (NBFC), Personal Emergency Line of Credit | Growth stage | 75000000 USD |  Hyderabad, Telangana |
| Geneos Therapeutics | Dec 4, 2023 | Biotherapeutics, Cancer Immunotherapy, Cancer Treatment, GT-EPIC Platform, GT-EPIC™ platform, Immune Checkpoint Inhibitor, Personalized Cancer Vaccine, Personalized Medicine, Personalized Therapeutic Cancer Vaccines | Early stage | 5000000 USD | Plymouth Meeting, Pennsylvania |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.